The Critical Role of T Cells in Glucocorticoid-Induced Osteoporosis

Lin Song,Lijuan Cao,Rui Liu,Hui Ma,Yanan Li,Qianwen Shang,Zhiyuan Zheng,Liying Zhang,Wen Zhang,Yuyi Han,Xiaoren Zhang,Huilin Yang,Ying Wang,Gerry Melino,Changshun Shao,Yufang Shi

DOI: https://doi.org/10.1038/s41419-020-03249-4

2020-01-01

Cell Death and Disease

Abstract:Glucocorticoids (GC) are widely used clinically, despite the presence of significant side effects, including glucocorticoid-induced osteoporosis (GIOP). While GC are believed to act directly on osteoblasts and osteoclasts to promote osteoporosis, the detailed underlying molecular mechanism of GC-induced osteoporosis is still not fully elucidated. Here, we show that lymphocytes play a pivotal role in regulating GC-induced osteoporosis. We show that GIOP could not be induced in SCID mice that lack T cells, but it could be re-established by adoptive transfer of splenic T cells from wild-type mice. As expected, T cells in the periphery are greatly reduced by GC; instead, they accumulate in the bone marrow where they are protected from GC-induced apoptosis. These bone marrow T cells in GC-treated mice express high steady-state levels of NF-κB receptor activator ligand (RANKL), which promotes the formation and maturation of osteoclasts and induces osteoporosis. Taken together, these findings reveal a critical role for T cells in GIOP.